Parkinson disease drug screening based on the interaction between D2 dopamine receptor and beta-arrestin 2 detected by capillary zone electrophoresis

{{article.zuoZheEn}}

PDF(127 KB)
PDF(127 KB)
Protein Cell ›› 2011, Vol. 2 ›› Issue (11) : 899-905. DOI: 10.1007/s13238-011-1096-0
COMMUNICATION

Parkinson disease drug screening based on the interaction between D2 dopamine receptor and beta-arrestin 2 detected by capillary zone electrophoresis

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Prot Cell, 2011, 2(11): 899‒905 https://doi.org/10.1007/s13238-011-1096-0

References

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
PDF(127 KB)

Accesses

Citations

Detail

Sections
Recommended

/